The State of Cybersecurity: Morgan Adamski at the 2024 ACFE Government Anti-Fraud Summit

The State of Cybersecurity: Morgan Adamski at the 2024 ACFE Government Anti-Fraud Summit

Morgan Adamski, the Executive Director of U.S. Cyber Command, discussed the importance of staying vigilant against cyber threats at the 2024 ACFE Government Anti-Fraud Summit. With a background as a senior executive at the National Security Agency (NSA), Adamski enlightened attendees on U.S. Cyber Command’s missions, the strategic cybersecurity threat environment and the importance of public-private partnerships in enhancing national security.

Read More

Conmen and Development Grants: A Case Study

Conmen and Development Grants: A Case Study

At the 35th Annual ACFE Global Fraud Conference, Daniel Porter, CFE, a speaker and investigative fraud consultant at D. Porter Solutions, presented a captivating session titled “Two Conmen + One Development Grant = $3M Fraud”. His presentation detailed a complex case of grant fraud involving two cunning individuals and a mismanaged development grant that resulted in a $3 million loss.

Read More

Identifying and Preventing Remote Employment Scams

Identifying and Preventing Remote Employment Scams

In today's post-COVID landscape, where remote work is commonplace, the risk of employment-related fraud has surged, posing significant challenges for organizations worldwide. At the 35th Annual ACFE Global Fraud Conference, Christopher DeAngelis, CFE, vice president of enterprise fraud strategies at Zellis, addressed this pressing issue in his session titled, "Are You Sure Your Remote Employee is Real?" 

Read More

Provider Fraud: Why Due Diligence Matters in Health Care Acquisitions

Provider Fraud: Why Due Diligence Matters in Health Care Acquisitions

During the 35th Annual ACFE Global Fraud Conference, Leah Lane, CFE, a director at SunHawk Consulting, presented a compelling session titled "A Case Study in Provider Fraud." Drawing from her extensive experience, Lane provided a detailed examination of the risks, misconduct and repercussions resulting from a health care company’s acquisition.

Read More